Trial · NCT04625283
Results by group22
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 22
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Length of Stay | Ketamine | 5.0 | Inter-Quartile Range 4.0 to 8.0 | days | |
| Length of Stay | Saline | 5.0 | Inter-Quartile Range 3.0 to 7.2 | days | |
| Total Consumption of Inpatient Opioids | Ketamine | 82.5 | Inter-Quartile Range 37.5 to 158.0 | MME | |
| Total Consumption of Inpatient Opioids | Saline | 90.0 | Inter-Quartile Range 45.0 to 158.0 | MME | |
| Number of Participants With Ileus | Ketamine | 71 | Participants | ||
| Number of Participants With Ileus | Saline | 37 | Participants | ||
| Number of Participants Who Encounter Rapid Response Team Activation | Ketamine | 39 | Participants | ||
| Number of Participants Who Encounter Rapid Response Team Activation | Saline | 26 | Participants | ||
| Number of Participants Who Experienced ICU Transfer | Ketamine | 44 | Participants | ||
| Number of Participants Who Experienced ICU Transfer | Saline | 22 | Participants | ||
| Number of Participants Who Experienced Adverse Side Effects | Ketamine | Met Early Discharge Milestones | 96 | Participants | |
| Number of Participants Who Experienced Adverse Side Effects | Saline | Met Early Discharge Milestones | 130 | Participants | |
| Number of Participants Who Experienced Adverse Side Effects | Ketamine | Patient Preference for Mild Side Effects | 83 | Participants | |
| Number of Participants Who Experienced Adverse Side Effects | Saline | Patient Preference for Mild Side Effects | 39 | Participants | |
| Number of Participants Who Experienced Adverse Side Effects | Ketamine | Debilitating Hallucinations | 19 | Participants | |
| Number of Participants Who Experienced Adverse Side Effects | Saline | Debilitating Hallucinations | 7 | Participants | |
| Number of Participants Who Experienced Adverse Side Effects | Ketamine | Debilitating Dizziness | 64 | Participants | |
| Number of Participants Who Experienced Adverse Side Effects | Saline | Debilitating Dizziness | 11 | Participants | |
| Number of Participants Who Experienced Adverse Side Effects | Ketamine | Hemodynamic Instability | 12 | Participants | |
| Number of Participants Who Experienced Adverse Side Effects | Saline | Hemodynamic Instability | 6 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04625283/results